‘An Arm and a Leg’: The New Cap on Medicare Drug Costs

Can’t see the audio player? Click here to listen. Click here for a transcript of the episode. On a Sunday afternoon in August, health services researcher Stacie Dusetzina was sitting alone in her office at Vanderbilt University, watching C-SPAN and crying. The U.S. Senate was voting on the Inflation Reduction Act, which among other things is designed to ensure that people on Medicare pay less for expensive drugs. It’s a big deal. Lots of seniors pay $10,000 a year or more for drugs or do without lifesaving treatment; once the new law kicks in, it sets an out-of-pocket limit of $2,000 a year.  Dusetzina and her colleagues have spent years maki...

Read the full post at Syndicate – Kaiser Health News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive